HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terry Plasse Selected Research

semapimod

6/2010A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
12/2004Macrophage inhibitor, semapimod, reduces tumor necrosis factor-alpha in myocardium in a rat model of ischemic heart failure.
1/2002Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Terry Plasse Research Topics

Disease

2Crohn Disease (Crohn's Disease)
06/2010 - 01/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2010
1Inflammation (Inflammations)
06/2010
1Phlebitis
06/2010
1Heart Failure
12/2004
1Infarction (Infarctions)
12/2004
1Myocardial Infarction
12/2004
1Birth Weight (Birth Weights)
03/2003
1Ulcer
01/2002

Drug/Important Bio-Agent (IBA)

3semapimodIBA
06/2010 - 01/2002
2CytokinesIBA
06/2010 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2004 - 01/2002
1C-Reactive ProteinIBA
06/2010
1salicylhydroxamic acid (SHAM)IBA
12/2004
1Pharmaceutical PreparationsIBA
12/2004
1Mannitol (Osmitrol)FDA LinkGeneric
12/2004
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2003
1Docosahexaenoic AcidsIBA
03/2003
1Phosphotransferases (Kinase)IBA
01/2002
1Mitogen-Activated Protein KinasesIBA
01/2002

Therapy/Procedure

1Ligation
12/2004